Human Robot Brewing taking over former Crime and Punishment space
Crime and Punishment Brewing shuttered last week after 10 years in operation in Philadelphia's Brewerytown neighborhood.
Human Robot Brewing is taking over the former home of Crime and Punishment Brewing in Brewerytown.
The West Kensington brewery closed on its $760,000 purchase of the building at 2711 W. Girard Ave. on Tuesday, Human Robot co-founder Jake Atkinson told the Business Journal. The deal did not include the Crime and Punishment business or any licenses.
Human Robot bought the building from Crime and Punishment Brewing owner Mike Paul. The brewery closed on April 15 after 10 years in operation.
GET TO KNOW YOUR CITY
Find Local Events Near You
Connect with a community of local professionals.
Explore All Events
In the ground-floor space previously home to Crime and Punishment Brewing, Human Robot plans to open a taproom that will operate under the name Human Robot Girard. The location is meant to replace the brewery's Schuylkill Banks location at 2401 Walnut St., which shutters on May 31. Human Robot subleases that space from Montreal-style bagel maker Spread Bagelry, which decided not to renew its lease in the building after it expires next month.
Atkinson said the turnkey nature of the space will allow Human Robot to get the taproom up and running as quickly as possible. The brewery is keeping all of Crime and Punishment's furniture and fixtures, except for the brewing equipment in the back room, which will be converted into another seating area for customers. The location will also offer outdoor seating.
All three staff members from Crime and Punishment have been offered positions at Human Robot Girard, according to Atkinson. The brewery will also relocate its two employees from Human Robot Schuylkill Banks to the Brewerytown outpost.
expand
Human Robot Brewing opened in Philadelphia's Kensington neighborhood in 2020.
Ryan Sharrow / Philadelphia Business Journal
The interior of the space, Atkinson said, will remain largely the same as it looked during its Crime and Punishment days.
"We're not going to change much," he said. "It's not like they didn't do well there. The neighborhood loved them."
Human Robot Girard will offer a limited food menu curated by Rich "Poe" Tamaccio, who runs Poe's Sandwich Joint at the brewery's flagship location at 1710 N. 5th St. in West Kensington, which opened in 2020. It will serve the same beers that it offers at its other taprooms.
Atkinson said the brewery also hopes to work with Crime and Punishment Brewing's Paul to make new beers for the taproom in the future.
"We really want to honor the tradition of that space and what he's already done in the community and not just come in and change everything up," Atkinson said.
The three-story, 3,700-square-foot Brewerytown building also has one vacant apartment on each of the top two levels. Atkinson said Human Robot plans to refurbish the two apartments and put them up for rent by August.
This will be Human Robot's second new taproom in the works. The brewery also plans to open a tasting room at 12 W. Mechanic St. in New Hope. Atkinson said the group is shooting for a July 1 opening date for that location.
In addition to its West Kensington brewery, Human Robot also operates taprooms at 1646-1648 S. 12th St. in South Philadelphia and in the suburbs at 208-210 York Road in Jenkintown. Those locations opened in 2023 and 2022, respectively.
Sign up here for the Philadelphia Business Journal's free newsletters, and download our free app for breaking news alerts.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per share Upfront and total potential cash consideration represent respectively a 126% and 216% premium to Nasdaq closing price on date prior to announcement of Future Pak's initial non-binding proposal Transaction with Future Pak represents culmination of sale process whereby Theratechnologies solicited interest from a number of potential counterparties Board unanimously recommends that shareholders approve the transaction MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ('Theratechnologies' or the 'Company') (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the 'Purchaser'), an affiliate of Future Pak, LLC ('Future Pak'), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right ('CVR') per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the 'Transaction'). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million. The cash portion of the consideration offered to the Company's shareholders under the Transaction and the combined cash and CVR consideration (assuming maximum payment of the CVR) represent substantial and compelling premiums of 126% and 216%, respectively, to the closing price on the Nasdaq Capital Market ('Nasdaq') on April 10, 2025, the date prior to the announcement of Future Pak's initial non-binding proposal, and of 90% and 165%, respectively, to the 30-day volume weighted average share price for the period ending on April 10, 2025. The arrangement agreement is the result of the sale process previously announced by the Company that was led by a special committee of independent directors of the Company (the 'Special Committee'). 'This transaction is the result of a thorough and deliberate sale process aimed at maximizing value for our shareholders,' stated Frank A. Holler, Chair of the Board of Directors of Theratechnologies. 'Future Pak's interest in acquiring Theratechnologies represents a vote of confidence in the company we've built, recognizing our achievements in bringing innovative medicines to patients and the outstanding contributions of our dedicated employees.' 'This acquisition marks a watershed moment in the nearly 50-year history of Future Pak, and the evolution of a growth strategy implemented nearly a decade ago,' said Nirav Patel, Chief Growth Officer at Future Pak. 'The addition of the Theratechnologies' portfolio will expand our reach, drive further growth and enhance patient access. We are excited to take this next step with Theratechnologies and look forward to unlocking its full potential, while maintaining a steadfast focus on patient care, quality and a continuous supply of product to the market. This transaction would not be possible but for the immeasurable contributions of both past and present Future Pak employees dating back to its founding in 1977.' Details of the Transaction Pursuant to the Transaction, the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one CVR per share, which will entitle the holder thereof to additional aggregate cash payments of up to US$1.19 per CVR, if the following Company milestones are achieved, subject to a maximum aggregate payment of US$65 million to all holders of CVRs: for the 12-month period ending on each of the 12-, 24- and 36- month anniversaries of the closing of the Transaction, if the EGRIFTA franchise gross profit for such 12-month period surpasses US$40 million, 50% of the profits surpassing such figure will be distributed pro rata to CVR holders within 45 days of the end of each such 12-month period; if the cumulative EGRIFTA franchise gross profit during the 36-month period following the closing of the Transaction exceeds US$150 million, a one-time payment of US$10 million will be distributed pro rata to CVR holders within 30 business days of the achievement of such milestone; and if the cumulative gross profit from the EGRIFTA and Trogarzo franchises during the 36-month period following the closing of the Transaction exceeds US$250 million, a one-time payment of US$15 million will be distributed pro rata to CVR holders within 30 business days of the achievement of such milestone. In each of the above instances, should the relevant milestones not be met, then no additional consideration will be payable to the holders of CVRs in relation to such milestone. The holders of exchangeable subscription receipts ('Subscription Receipts') and deferred share units ('DSUs') will receive the cash consideration per share plus one CVR for each Subscription Receipt or DSU held. The holders of 'in the money' options to acquire common shares ('Options') and share appreciation rights ('SARs') will receive an amount by which the cash consideration exceeds the exercise price of the Options or SARs, plus one CVR for each Option or SAR held. Each 'out of the money' Option and SAR outstanding with an exercise price greater than the cash consideration will be entitled to a portion of the value of a CVR, which portion shall be equal to the amount by which the cash consideration plus the value of such whole CVR exceeds the exercise price of such Option or SAR. Holders of warrants to purchase common shares ('Warrants') will receive the amount by which the cash consideration exceeds the exercise price of the Warrants, multiplied by one quarter, plus one CVR for every four warrants held. Each CVR will be a direct obligation of the Purchaser. The CVRs will not be listed on any market or exchange, and may not be sold, assigned, transferred, pledged or encumbered in any manner, other than in limited circumstances to be described in the CVR agreement to be entered into at closing of the Transaction, a form of which is included in the arrangement agreement. The CVRs will not represent any equity or ownership interest in the Company, the Purchaser, Future Pak or any affiliate thereof (or any other person) and will not be represented by any certificates or other instruments. The CVRs will not have any voting or dividend rights, and no interest will accrue on any amounts payable on the CVRs to any holder thereof. The Transaction will be implemented by way of a plan of arrangement under the Business Corporations Act (Québec) and is expected to close during the Company's fourth quarter ending November 30, 2025, subject to customary closing conditions, including the receipt of required shareholder approval and the approval of the Superior Court of Québec. The Transaction will be funded by Future Pak through a combination of debt financing and cash on hand. Future Pak has received a debt commitment letter from its lenders for a US$220 million credit facility. The debt financing is subject to limited conditions. Required shareholder approval for the Transaction will consist of (i) at least 66⅔% of the votes cast on the Transaction by holders of common shares at a special meeting of shareholders of the Company, and (ii) at least a majority of the votes cast on the Transaction by holders of common shares, excluding shares held by shareholders required to be excluded pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ('MI 61-101'), at such meeting. Concurrently with the execution of the arrangement agreement, the Purchaser has entered into voting support agreements with members of senior management and all of the directors of the Company, together holding shares representing approximately 1.14% of the issued and outstanding common shares of the Company, pursuant to which they have agreed to vote all shares held by them in favour of the Transaction, subject to customary exceptions. The arrangement agreement contains non-solicitation covenants on the part of the Company, subject to customary 'fiduciary out' and 'right to match' provisions. A termination fee of US$6 million would be payable by the Company to the Purchaser in certain circumstances, including in the context of a superior proposal supported by the Company. The Company would also be entitled to a reverse termination fee of US$12 million payable by the Purchaser to the Company if the Transaction is not completed in certain circumstances. Following completion of the Transaction, the Company will become a privately held company, will apply to cease to be a reporting issuer under Canadian securities laws and will deregister its shares with the U.S. Securities and Exchange Commission. The common shares will no longer be publicly traded on the Toronto Stock Exchange and on the Nasdaq. Additional information regarding the Transaction will be included in an information circular that the Company will prepare, file and mail to its shareholders in advance of the special meeting to be held to consider and approve the Transaction. Copies of the arrangement agreement and the information circular will be available under the Company's profile on SEDAR+ on and on EDGAR as an exhibit to the Schedule 13E-3 Transaction Statement to be filed by the Company at Theratechnologies Board Recommendation Theratechnologies' Board of Directors, having received the unanimous recommendation of the Special Committee, has unanimously determined that the Transaction is in the best interests of the Company and is fair to its shareholders (other than those shareholders whose votes are required to be excluded for the purposes of 'minority approval' under MI 61-101), and unanimously recommends that the Company's shareholders approve the Transaction. Each of Barclays Capital Inc., as exclusive financial advisor to the Company and the Special Committee, and Raymond James Ltd., retained to provide independent financial advisory services to the Special Committee, has provided a fairness opinion to the Board of Directors and the Special Committee to the effect that, as at July 2, 2025, and based upon and subject to the assumptions, limitations and qualifications stated therein, the consideration to be received by shareholders pursuant to the Transaction is fair, from a financial point of view, to the shareholders of the Company. Copies of the fairness opinions, as well as additional details regarding the terms and conditions of the Transaction, will be set out in the management proxy circular to be filed by the Company on its profile on SEDAR+ at and on EDGAR as an exhibit to the Schedule 13E-3 Transaction Statement to be filed by the Company at Advisors Barclays Capital Inc. is acting as exclusive financial advisor to the Company and to the Special Committee, and Raymond James Ltd. is acting as independent financial advisor to the Special Committee. Fasken Martineau DuMoulin LLP is acting as legal advisor to the Company and the Special Committee, and Norton Rose Fulbright Canada LLP is acting as independent legal advisor to the Special Committee. Bourne Partners Securities is acting as exclusive financial advisor to Future Pak and Honigman LLP and McMillan LLP are acting as its legal advisors. DPO&Co provided transaction advisory services to Future Pak. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at on SEDAR+ at and on EDGAR at Follow Theratechnologies on LinkedIn and X. About Future Pak Founded in 1977 and headquartered in Wixom, Michigan, Future Pak, along with its affiliates, is a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products. Future Pak operates across retail, specialty and institutional markets, leveraging its robust infrastructure and partner network to deliver quality-first, patient-centric solutions. Forward-Looking Information This press release contains forward-looking statements and forward-looking information (collectively, 'Forward-Looking Statements'), within the meaning of applicable securities laws, that are based on our management's beliefs and assumptions and on information currently available to our management. You can identify Forward-Looking Statements by terms such as 'may', 'will', 'if', 'should', 'could', 'promising', 'would', 'outlook', 'believe', 'plan', 'envisage', 'anticipate', 'expect' and 'estimate', or the negatives of these terms, or variations of them. The Forward-Looking Statements contained in this press release include, but are not limited to: the proposed Transaction, including the proposed timing and various steps contemplated in respect of the Transaction; the anticipated benefits of the Transaction for the Company and its shareholders; shareholder and Court approvals; the anticipated timing of completion of the Transaction; the achievement of the CVR milestones and the payout of any additional amounts to holders of CVRs; statements relating to Future Pak's financing; and other statements that are not historical facts. Although the Forward-Looking Statements contained in this press release are based upon what the Company believes are reasonable assumptions in light of the information currently available, investors are cautioned against placing undue reliance on this information since actual results may vary from the Forward-Looking Statements. Forward-Looking Statements assumptions are subject to a number of risks and uncertainties, many of which are beyond Theratechnologies' control, that could cause actual results to differ materially from those that are disclosed in or implied by such Forward-Looking Statements. These risks and uncertainties include, but are not limited to: the possibility that the Transaction will not be completed on the terms and conditions or on the timing currently contemplated, and that it may not be completed at all, due to a failure to obtain or satisfy, in a timely manner or otherwise, required shareholder and Court approvals and other conditions to the closing of the Transaction or for other reasons; the failure of Future Pak to enter into a definitive agreement with respect to the debt financing; the failure to complete the Transaction which could negatively impact the price of the shares or otherwise affect the business of the Company; the dedication of significant resources to pursuing the Transaction and the restrictions imposed on the Company while the Transaction is pending; the uncertainty surrounding the Transaction that could adversely affect the Company's retention of customers and business partners; the occurrence of a material adverse effect leading to the termination of the arrangement agreement; credit, market, currency, operational, commodity, geopolitical, liquidity and funding risks generally, including changes in economic conditions, interest rates or tax rates; and other risks inherent to the Company's business and/or factors beyond its control which could have a material adverse effect on the Company or its ability to consummate the Transaction. For further details, please see the 'Risk Factors' section of the Company's Annual Information Form filed on Form 20-F dated February 26, 2025 available on SEDAR+ at and on EDGAR at under Theratechnologies' public filings for the risks associated with the business. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on Forward-Looking Statements. Forward-Looking Statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date. Contact Information: Theratechnologies Inc. Investor inquiries: Philippe Dubuc Senior Vice President and Chief Financial Officer pdubuc@ 438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@ Future PakInvestors and media may contact media@
Miami Herald
6 hours ago
- Miami Herald
Popular pizza chain franchisees close locations, no bankruptcy
The pizza restaurant sector has battled rising operating costs since before the Covid-19 pandemic, which forced some businesses to reorganize and restructure debt. Increased food and labor costs driven by rising inflation took their toll on the pizza dining industry. The average cost of food increased by 29%, and labor costs rose by 31% from 2019 to 2024, according to the National Restaurant Association. Don't miss the move: Subscribe to TheStreet's free daily newsletter Menu prices also increased, as average prices rose by 27.2% from February 2020 to June 2024. Related: Popular restaurant chain franchisee files Chapter 11 bankruptcy Add fierce competition to the equation, and the economic challenges can force restaurants to restructure their businesses out of court, reorganize in a Chapter 11 bankruptcy, sell assets, and sometimes permanently shut down. In some cases, pizza chains or their franchisees will file for Chapter 11 bankruptcy to reorganize and continue as a going concern. East Coast pizza chain Bertucci's Restaurants has used the bankruptcy court successfully to reorganize and remain in business, as it filed for Chapter 11 protection three times in seven years. Bertucci's filed for Chapter 11 bankruptcy the first time in April 2018 to sell its assets, and it operated 31 restaurants when it filed for bankruptcy protection in December 2022. Bertucci's filed for bankruptcy a third time on April 24, 2025, and had 15 remaining restaurants in its chain when it filed. Franchisees of major pizza chains also filed for bankruptcy protection to sell or close locations. Huge Pizza Hut operator EYM Pizza L.P. filed for Chapter 11 bankruptcy protection in July 2024 and sold 77 of its restaurants at a bankruptcy auction. Legendary Buddy's Pizza, which claims to have invented the iconic square-shaped Detroit-style pizza, closed its Portage, Mich., location, suffering lingering effects from the Covid pandemic, supply chain disruptions, staffing shortages, and rising costs of inflation. The company did not file for bankruptcy. Buddy's Pizza currently operates 15 full-service pizza restaurants throughout Michigan, and another five carry-out only locations. Finally, CiCi's Pizza chain franchisees in Alabama and Florida have closed several restaurant locations, but also have not filed for bankruptcy protection. Related: Popular restaurant chain files bankruptcy, closes locations The pizza chain's Alabama franchisee Buckshot Enterprises LLC recently closed three locations in Florence, Northport, and Huntsville, Ala., Tuscaloosa Thread reported. The three locations were reportedly closed, according to social media posts and signs on the businesses' doors. More bankruptcy: Iconic auto repair chain franchise files Chapter 11 bankruptcyPopular beer brand closes down and files Chapter 7 bankruptcyPopular vodka and gin brand files for Chapter 11 bankruptcy The Florence location reportedly closed permanently in mid-June, the Northport restaurant's last day of operation was on June 29, and the Huntsville location has not been confirmed as closed, but the business's phone was not operating during normal store hours. Calls to all three Alabama locations were not answered. Another longtime CiCi's location in Uptown Center in North Naples. Fla., closed on June 9 after operating for almost 20 years, Gulfshore Business reported. The local franchisee reportedly decided not to renew his franchise agreement with the national restaurant chain, since he didn't want to commit to another 10 years. If the franchisee renewed his agreement, he would have to bring his 20-year-old store up to the company's latest specifications, which would be costly. Franchisee Philip Santucci was unsuccessful in trying to find someone to take over the franchise. He said a transaction was a hard sell, since the business and all its equipment are 20 years old, and it would be expensive to remodel the restaurant and buy new equipment. Santucci was the original general manager when the restaurant opened in 2004, and he bought the franchise five years ago in 2019 before the Covid-19 pandemic. The restaurant recovered from the pandemic in about two years. The restaurant owner, however, said it was time for him personally to move on. CiCi's Pizza, founded in 1985, has about 270 locations in 22 states, according to its website. Related: Iconic San Francisco restaurant closes permanently after 40 years The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
New York Post
9 hours ago
- New York Post
Bryan Kohberger's plea deal leaves these burning questions unanswered
Bryan Kohberger pleaded guilty Wednesday to the premeditated slaughter of four University of Idaho undergrads — but there remain a slew of glaring loose ends. Prosecutors gave a step-by-step timeline of the 30-year-old killer's actions before, during, and after the pre-dawn attack in Moscow, Idaho, they failed to explain Kohberger's possible motive. But the 'why?' wasn't the only burning question that has tantalized followers of the case for two and a half years. Where is the knife? Kohberger purchased a KA-BAR military-style knife, sheath, and sharpener from Amazon in March, 2022 – months before he even moved to the area, prosecutors said. 8 Bryan Kohberger at his extradition hearing. Paul Martinka 8 Final photo of the victims, pictured just hours before their untimely deaths. Police recovered the knife sheath at the crime scene with his DNA on it, but the murder weapon itself was nowhere to be found. Cell phone tower records place Kohberger's phone near a rural village outside Moscow at around 4:45 a.m., roughly a half hour after the killings, which means he could have ditched it in any number of Idaho fields and pastures along the way. Did Kohberger know any of the victims, and why did he target them? Kohberger didn't break into a random house: Cell phone tower records placed Kohberger in the victims' neighborhood 23 times in the months before the murders, and security camera footage shows his car circling their block like a shark before finally moving in for the kill. Early reports claimed Kohberger had cyberstalked one of the victims and bombarded her with Instagram messages, but his lawyers later insisted he had no connection to the victims at all. So how did he know about Kaylee Goncalves, Xana Kernodle, Madison Mogen and Ethan Chapin? The only hint prosecutors offered on Wednesday was suggesting Kohberger might not have entered the house intending to kill all four victims. 8 The house in Moscow, ID, where four University of Idaho students were knifed to death. Kevin C. Downs for NY Post 8 The four victims: Kaylee Goncalves, top left; Xana Kernodle, top right; Ethan Chapin, bottom left; and Madison Mogen, bottom right. Whose ID did Kohberger have hidden at his parents' house? In 2023, a police source told NewsNation investigators had found an ID 'connected to someone from the quadruple homicide' carefully hidden at Kohberger's parents' house. The report prompted frenzied speculation that Kohberger had kept a victim's ID as a souvenir. That now seems unlikely: A victim's ID would have been a major piece of physical evidence and would likely have come up in the courtroom. But the ID could have been any number of things: A fake ID for a potential escape off the grid, or even just the Amazon gift card prosecutors said he used to purchase the knife. One colorful theory suggests Kohberer had a Joker-style calling card to leave at the scenes of future murders. Whatever it was, we'll likely never know. Is Kohberger a psychopath? Kohberger's defense revealed that he had OCD and mild autism, but they said those traits has no bearing on the crimes he was accused of. 8 Judge Steven Hippler rejecting a motion to drop the death penalty. TNS 8 Kohberger at a court hearing. His defense used an autism diagnosis to explain his distinctive, dead-eyed stare. AP A jury trial could have involved psychological evaluations of Kohberger and evidence for what psychologists call 'dark tetrad' personality traits: Narcissism, sadism, Machiavellian manipulativeness, and, of course, psychopathy. 8 Bryan Kohberger appears for his July 2 plea hearing. AP 8 Two University of Idaho victims, Madison Mogen and Xana Kernodle. Instagram / @xanakernodle Why did Kohberger return to the scene of the crime? Cell phone tower records suggest Kohberger went back to his victim's neighborhood roughly five hours after the bloody deed. Was it to recover a piece of evidence, perhaps even the missing knife? Or just to admire his deadly handiwork? He certainly seemed to be proud of himself, as evidenced by a grinning, 'thumbs up' selfie he took when he got home.
